Drug intelligence / Profile preview

siRNA targeting transferrin receptor 1

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

siRNA targeting transferrin receptor 1 (TfR1) is a small interfering RNA designed to knock down the expression of TfR1 (also known as CD71), a transmembrane glycoprotein that mediates cellular iron uptake. In preclinical research, silencing TfR1 with siRNA has been investigated as a therapeutic strategy to reduce intracellular iron accumulation, oxidative stress, and ferroptosis. It has been studied in in vitro models of hemophilic synovitis, pyogenic spondylitis, and osteoarthritis to disrupt the vicious cycle of iron overload and inflammatory signaling (such as the NF-κB and cGAS/STING pathways).

Other names
TfR1 siRNATfR-1 siRNATfR 1 siRNAsi-TfR1si-TfR-1si-TfR 1siRNA targeting TfR1
02

Targets

TFRC (Transferrin Receptor)

Beyond the preview

Go deeper on siRNA targeting transferrin receptor 1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siRNA targeting transferrin receptor 1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call